Beta-blocker dose adjustment for older heart failure patients
Part of Heart & circulation clinical trials.
This study helps older adults with heart failure gradually increase their beta-blocker dose to a level that guidelines recommend, using an approach tailored to each person.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years old or older
- You have heart failure with reduced pumping function (LVEF below 40%)
- Your current beta-blocker dose is less than half of the recommended target (for example, less than 100 mg metoprolol, 12.5 mg carvedilol twice a day, or 5 mg bisoprolol daily)
- You do not have a condition that makes beta-blockers unsafe for you, such as an allergy
- Your doctor approves of you taking part in this trial
- Your heart condition is stable
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at an “informed” approach to help manage HFpEF (a type of heart failure) in people age 65 and older. It checks whether a structured plan and monitoring are practical and safe for you over time.
This study uses a smartphone app to test how different beta blocker doses work best for you. It's for older adults with stable heart failure who want to fine-tune their treatment.
This trial tests whether it is safe to gradually stop beta-blocker medication in older adults with heart failure with preserved ejection fraction (a type of heart failure where the heart pumps normally but is stiff). It aims to improve quality of life by reducing unnecessary medications.
This trial tests whether a genetic test can help doctors choose the best beta blocker for people with heart failure who have mildly reduced pumping function. It aims to improve treatment by matching the drug to your genetic profile.
This trial tests whether people whose heart function has returned to normal after heart failure can safely stop taking beta-blockers. It aims to see if staying on the medication is still needed or if stopping is just as safe.
This study tests whether patients whose heart failure has improved can safely reduce some of their medications. If your heart function has recovered significantly and stayed stable, this trial explores whether you can gradually lower doses of heart failure drugs while staying healthy.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.